This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
You’ve arranged to speak with a reporter. Do you know how to deliver insights that are memorab...
Adverse and derogatory information often has devastating effects on a contractor's ability to win co...
Class action litigation presents significant legal and business challenges for employers and corpora...
The United States Constitution is one of the most influential legal documents in history, establishi...
This course on trade secrets litigation provides real-world best practices through all key stages of...
During this course you will take a deep dive into federal bid protest litigation at the U.S. Court o...
Confidentiality Agreements (also called NDAs) are too often treated as routine. So routine, th...
This program provides trial attorneys with a thorough grounding in the three principal currency repo...
During this course you will learn about the Federal Firearm Rights Restoration program and the Feder...
“Is Your Voice Biometric Data? BIPA, AI and the New Era of Voiceprint Litigation” looks ...